These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
200 related articles for article (PubMed ID: 34075790)
41. Clinical associations between ASCT2 and p‑mTOR in the pathogenesis and prognosis of epithelial ovarian cancer. Guo H; Xu Y; Wang F; Shen Z; Tuo X; Qian H; Wang H; Wang K Oncol Rep; 2018 Dec; 40(6):3725-3733. PubMed ID: 30272366 [TBL] [Abstract][Full Text] [Related]
42. Progesterone inhibits endometrial cancer growth by inhibiting glutamine metabolism through ASCT2. Guo J; Fan J; Zhang Y; Li M; Jin Z; Shang Y; Zhang H; Kong Y Biosci Rep; 2024 Mar; 44(3):. PubMed ID: 38415405 [TBL] [Abstract][Full Text] [Related]
43. Glutamine transporter ASCT2 was down-regulated in ischemic injured human intestinal epithelial cells and reversed by epidermal growth factor. Huang Q; Li N; Zhu W; Li Q; Li J JPEN J Parenter Enteral Nutr; 2007; 31(2):86-93. PubMed ID: 17308248 [TBL] [Abstract][Full Text] [Related]
44. Inhibition of glucose metabolism prevents glycosylation of the glutamine transporter ASCT2 and promotes compensatory LAT1 upregulation in leukemia cells. Polet F; Martherus R; Corbet C; Pinto A; Feron O Oncotarget; 2016 Jul; 7(29):46371-46383. PubMed ID: 27344174 [TBL] [Abstract][Full Text] [Related]
45. The expression of glutamine-metabolism-related proteins in breast phyllodes tumors. Kim S; Jung WH; Koo JS Tumour Biol; 2013 Oct; 34(5):2683-9. PubMed ID: 23636801 [TBL] [Abstract][Full Text] [Related]
46. Deletion of Amino Acid Transporter ASCT2 (SLC1A5) Reveals an Essential Role for Transporters SNAT1 (SLC38A1) and SNAT2 (SLC38A2) to Sustain Glutaminolysis in Cancer Cells. Bröer A; Rahimi F; Bröer S J Biol Chem; 2016 Jun; 291(25):13194-205. PubMed ID: 27129276 [TBL] [Abstract][Full Text] [Related]
47. Expression of glutamine metabolism-related proteins according to molecular subtype of breast cancer. Kim S; Kim DH; Jung WH; Koo JS Endocr Relat Cancer; 2013 Jun; 20(3):339-48. PubMed ID: 23507704 [TBL] [Abstract][Full Text] [Related]
48. Cross-talk between ER and HER2 regulates c-MYC-mediated glutamine metabolism in aromatase inhibitor resistant breast cancer cells. Chen Z; Wang Y; Warden C; Chen S J Steroid Biochem Mol Biol; 2015 May; 149():118-27. PubMed ID: 25683269 [TBL] [Abstract][Full Text] [Related]
49. Oncogenic KRAS mutations enhance amino acid uptake by colorectal cancer cells via the hippo signaling effector YAP1. Kandasamy P; Zlobec I; Nydegger DT; Pujol-Giménez J; Bhardwaj R; Shirasawa S; Tsunoda T; Hediger MA Mol Oncol; 2021 Oct; 15(10):2782-2800. PubMed ID: 34003553 [TBL] [Abstract][Full Text] [Related]
50. Glutamine Transporters Are Targets of Multiple Oncogenic Signaling Pathways in Prostate Cancer. White MA; Lin C; Rajapakshe K; Dong J; Shi Y; Tsouko E; Mukhopadhyay R; Jasso D; Dawood W; Coarfa C; Frigo DE Mol Cancer Res; 2017 Aug; 15(8):1017-1028. PubMed ID: 28507054 [TBL] [Abstract][Full Text] [Related]
51. A Variant of SLC1A5 Is a Mitochondrial Glutamine Transporter for Metabolic Reprogramming in Cancer Cells. Yoo HC; Park SJ; Nam M; Kang J; Kim K; Yeo JH; Kim JK; Heo Y; Lee HS; Lee MY; Lee CW; Kang JS; Kim YH; Lee J; Choi J; Hwang GS; Bang S; Han JM Cell Metab; 2020 Feb; 31(2):267-283.e12. PubMed ID: 31866442 [TBL] [Abstract][Full Text] [Related]
53. ASCT2 silencing regulates mammalian target-of-rapamycin growth and survival signaling in human hepatoma cells. Fuchs BC; Finger RE; Onan MC; Bode BP Am J Physiol Cell Physiol; 2007 Jul; 293(1):C55-63. PubMed ID: 17329400 [TBL] [Abstract][Full Text] [Related]
54. Metabolic Evaluation of MYCN-Amplified Neuroblastoma by 4-[ Li C; Huang S; Guo J; Wang C; Huang Z; Huang R; Liu L; Liang S; Wang H Mol Imaging Biol; 2019 Dec; 21(6):1117-1126. PubMed ID: 30850970 [TBL] [Abstract][Full Text] [Related]
55. TEAD1 (TEA Domain Transcription Factor 1) Promotes Smooth Muscle Cell Proliferation Through Upregulating SLC1A5 (Solute Carrier Family 1 Member 5)-Mediated Glutamine Uptake. Osman I; He X; Liu J; Dong K; Wen T; Zhang F; Yu L; Hu G; Xin H; Zhang W; Zhou J Circ Res; 2019 Apr; 124(9):1309-1322. PubMed ID: 30801233 [TBL] [Abstract][Full Text] [Related]
56. Asparagine transport through SLC1A5/ASCT2 and SLC38A5/SNAT5 is essential for BCP-ALL cell survival and a potential therapeutic target. Taurino G; Dander E; Chiu M; Pozzi G; Maccari C; Starace R; Silvestri D; Griffini E; Bianchi MG; Carubbi C; Andreoli R; Mirandola P; Valsecchi MG; Rizzari C; D'Amico G; Bussolati O Br J Haematol; 2024 Jul; 205(1):175-188. PubMed ID: 38736325 [TBL] [Abstract][Full Text] [Related]
57. Targeted Suppression and Knockout of ASCT2 or LAT1 in Epithelial and Mesenchymal Human Liver Cancer Cells Fail to Inhibit Growth. Bothwell PJ; Kron CD; Wittke EF; Czerniak BN; Bode BP Int J Mol Sci; 2018 Jul; 19(7):. PubMed ID: 30029480 [TBL] [Abstract][Full Text] [Related]
58. The role of the glutamine transporter ASCT2 in antineoplastic therapy. Teixeira E; Silva C; Martel F Cancer Chemother Pharmacol; 2021 Apr; 87(4):447-464. PubMed ID: 33464409 [TBL] [Abstract][Full Text] [Related]
59. Impairment of Myocardial Glutamine Homeostasis Induced By Suppression of the Amino Acid Carrier SLC1A5 in Failing Myocardium. Kennel PJ; Liao X; Saha A; Ji R; Zhang X; Castillero E; Brunjes D; Takayama H; Naka Y; Thomas T; George I; Mancini D; Schulze PC Circ Heart Fail; 2019 Dec; 12(12):e006336. PubMed ID: 31826641 [No Abstract] [Full Text] [Related]
60. Resveratrol enhances cisplatin-induced apoptosis in human hepatoma cells via glutamine metabolism inhibition. Liu Z; Peng Q; Li Y; Gao Y BMB Rep; 2018 Sep; 51(9):474-479. PubMed ID: 30103844 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]